IBDEI0UI ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14311,1,4,0)
 ;;=4^R63.2
 ;;^UTILITY(U,$J,358.3,14311,2)
 ;;=^5019540
 ;;^UTILITY(U,$J,358.3,14312,0)
 ;;=R63.3^^53^605^72
 ;;^UTILITY(U,$J,358.3,14312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14312,1,3,0)
 ;;=3^Feeding Difficulties
 ;;^UTILITY(U,$J,358.3,14312,1,4,0)
 ;;=4^R63.3
 ;;^UTILITY(U,$J,358.3,14312,2)
 ;;=^5019541
 ;;^UTILITY(U,$J,358.3,14313,0)
 ;;=R63.4^^53^605^29
 ;;^UTILITY(U,$J,358.3,14313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14313,1,3,0)
 ;;=3^Abnormal Weight Loss
 ;;^UTILITY(U,$J,358.3,14313,1,4,0)
 ;;=4^R63.4
 ;;^UTILITY(U,$J,358.3,14313,2)
 ;;=^5019542
 ;;^UTILITY(U,$J,358.3,14314,0)
 ;;=R63.5^^53^605^28
 ;;^UTILITY(U,$J,358.3,14314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14314,1,3,0)
 ;;=3^Abnormal Weight Gain
 ;;^UTILITY(U,$J,358.3,14314,1,4,0)
 ;;=4^R63.5
 ;;^UTILITY(U,$J,358.3,14314,2)
 ;;=^5019543
 ;;^UTILITY(U,$J,358.3,14315,0)
 ;;=R64.^^53^605^46
 ;;^UTILITY(U,$J,358.3,14315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14315,1,3,0)
 ;;=3^Cachexia
 ;;^UTILITY(U,$J,358.3,14315,1,4,0)
 ;;=4^R64.
 ;;^UTILITY(U,$J,358.3,14315,2)
 ;;=^17920
 ;;^UTILITY(U,$J,358.3,14316,0)
 ;;=R68.3^^53^605^51
 ;;^UTILITY(U,$J,358.3,14316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14316,1,3,0)
 ;;=3^Clubbing of Fingers
 ;;^UTILITY(U,$J,358.3,14316,1,4,0)
 ;;=4^R68.3
 ;;^UTILITY(U,$J,358.3,14316,2)
 ;;=^5019553
 ;;^UTILITY(U,$J,358.3,14317,0)
 ;;=R73.01^^53^605^89
 ;;^UTILITY(U,$J,358.3,14317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14317,1,3,0)
 ;;=3^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,14317,1,4,0)
 ;;=4^R73.01
 ;;^UTILITY(U,$J,358.3,14317,2)
 ;;=^5019561
 ;;^UTILITY(U,$J,358.3,14318,0)
 ;;=R73.02^^53^605^90
 ;;^UTILITY(U,$J,358.3,14318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14318,1,3,0)
 ;;=3^Impaired Glucose Tolerance (oral)
 ;;^UTILITY(U,$J,358.3,14318,1,4,0)
 ;;=4^R73.02
 ;;^UTILITY(U,$J,358.3,14318,2)
 ;;=^5019562
 ;;^UTILITY(U,$J,358.3,14319,0)
 ;;=R73.09^^53^605^15
 ;;^UTILITY(U,$J,358.3,14319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14319,1,3,0)
 ;;=3^Abnormal Glucose NEC
 ;;^UTILITY(U,$J,358.3,14319,1,4,0)
 ;;=4^R73.09
 ;;^UTILITY(U,$J,358.3,14319,2)
 ;;=^5019563
 ;;^UTILITY(U,$J,358.3,14320,0)
 ;;=R73.9^^53^605^84
 ;;^UTILITY(U,$J,358.3,14320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14320,1,3,0)
 ;;=3^Hyperglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,14320,1,4,0)
 ;;=4^R73.9
 ;;^UTILITY(U,$J,358.3,14320,2)
 ;;=^5019564
 ;;^UTILITY(U,$J,358.3,14321,0)
 ;;=R76.11^^53^605^142
 ;;^UTILITY(U,$J,358.3,14321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14321,1,3,0)
 ;;=3^Positive PPD
 ;;^UTILITY(U,$J,358.3,14321,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,14321,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,14322,0)
 ;;=R79.1^^53^605^3
 ;;^UTILITY(U,$J,358.3,14322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14322,1,3,0)
 ;;=3^Abnormal Coagulation Profile
 ;;^UTILITY(U,$J,358.3,14322,1,4,0)
 ;;=4^R79.1
 ;;^UTILITY(U,$J,358.3,14322,2)
 ;;=^5019591
 ;;^UTILITY(U,$J,358.3,14323,0)
 ;;=R82.5^^53^605^69
 ;;^UTILITY(U,$J,358.3,14323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14323,1,3,0)
 ;;=3^Elevated Urine Levels of Drug/Meds/Biol Subst
 ;;^UTILITY(U,$J,358.3,14323,1,4,0)
 ;;=4^R82.5
 ;;^UTILITY(U,$J,358.3,14323,2)
 ;;=^5019605
 ;;^UTILITY(U,$J,358.3,14324,0)
 ;;=R82.6^^53^605^26
 ;;^UTILITY(U,$J,358.3,14324,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14324,1,3,0)
 ;;=3^Abnormal Urine Levels of Subst of Nonmed Source
 ;;^UTILITY(U,$J,358.3,14324,1,4,0)
 ;;=4^R82.6
 ;;^UTILITY(U,$J,358.3,14324,2)
 ;;=^5019606
 ;;^UTILITY(U,$J,358.3,14325,0)
 ;;=R82.7^^53^605^27
